BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02390427-completion@plaintrial.com
DTSTAMP:20261028T002210Z
DTSTART;VALUE=DATE:202407
SUMMARY:Phase Ib Dose-escalation Trial of Taselisib (GDC-0032) in Combinati
 on With Anti-HER2 Therapies in Participants With Advanced HER2+ Breast Can
 cer — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT02390427
URL:https://plaintrial.com/trial/NCT02390427
END:VEVENT
END:VCALENDAR